Related Experiment Video
Updated: Oct 29, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
The Impact of Uric Acid and Hyperuricemia on Cardiovascular and Renal Systems
Davide Agnoletti1, Arrigo F G Cicero2, Claudio Borghi2
1Internal Medicine Department, IRCCS Sacro Cuore Hospital, Viale Luigi Rizzardi 4, Negrar di Valpolicella (VR) 37024, Italy.
Insights
Uric acid
Area of Science:
- Biochemistry
- Clinical Medicine
- Cardiovascular Research
Background:
- Gout has a 5000-year history, with uric acid implicated in its pathogenesis.
- Uric acid's role in oxidative stress, inflammation, and organ outcomes is extensively studied.
- Hyperuricemia management involves lifestyle changes and targeted therapies.
Purpose of the Study:
- To review the implications of uric acid in health and disease.
- To assess the efficacy of uric acid-lowering therapies on clinical outcomes.
- To highlight the need for further research on uric acid's cardiovascular effects.
Main Methods:
- Literature review of basic and clinical studies on uric acid.
- Analysis of data regarding uric acid-lowering therapy in hyperuricemia.
- Evaluation of evidence on cardiovascular and renal outcomes related to uric acid.
Main Results:
- Uric acid-lowering therapy did not improve hard outcomes in asymptomatic hyperuricemia.
- Therapy is reserved for symptomatic hyperuricemia.
- Dietary and lifestyle modifications are crucial for hyperuricemia management.
Conclusions:
- Current evidence does not support uric acid-lowering drugs for asymptomatic hyperuricemia.
- Symptomatic hyperuricemia warrants therapeutic intervention.
- Further investigation into the cardiovascular impact of uric acid-lowering drugs is necessary.
Abstract:
The description of gout dates back almost 5000 years, and scientific interest in uric acid increased when it was found to be involved in the pathogenesis of gout. Since then, many basic and clinical studies have assessed the implications of uric acid for the oxidative system, inflammation, and cardiovascular and renal outcomes. Uric acid-lowering therapy failed to improve clinical hard outcomes in asymptomatic hyperuricemia, and it is retained in symptomatic hyperuricemia. Dietary and lifestyle modifications are critical to manage hyperuricemia. More studies are warranted to investigate the role of uric acid-lowering drugs on cardiovascular outcomes.
More Related Videos
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Antihypertensive Drugs: Action of Diuretics
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Hypertension and Regulation of Blood Pressure
Cardiovascular Drugs: Classification based on Therapeutic Indications
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

![Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F61682.jpg&w=3840&q=50)